Frank M. Armstrong

Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months

G. Sundkvist, Frank M. Armstrong, Jean E. Bradbury et al. · Journal of Diabetes and its Complications · 1992 · 60 citations

Peripheral Neuropathy, Diabetes Management, Diabetes +8

A Study of Peripheral Diabetic Neuropathy. The Application of Age‐Related Reference Values

Frank M. Armstrong, Jean E. Bradbury, Stuart H. Ellis et al. · Diabetic Medicine · 1991 · 58 citations

Great Toe, Aging, Peripheral Nerve Injury +25

Aldose reductase in the etiology of diabetic complications 3. Neuropathy

D. Sloan Stribling, Frank M. Armstrong, C. M. Perkins et al. · Journal of Diabetic Complications · 1989 · 11 citations

Metabolic Syndrome, Diabetes Management, Aldose Reductase +9